Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy

Breast Cancer Research and Treatment

Volumn 135, Issue 1, 2012, Pages 231-240

  Koolen, Bas B ^a   Valdés Olmos, Renato A ^a   Elkhuizen, Paula H M ^a   Vogel, Wouter V ^a   Vrancken Peeters, Marie Jeanne T F D ^a   Rodenhuis, Sjoerd ^a   Rutgers, Emiel J Th ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Breast cancer; Lymph node; Neoadjuvant chemotherapy; PET CT; Radiotherapy; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL; TRASTUZUMAB;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BODY POSTURE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; PATIENT MONITORING; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; YOUNG ADULT;

EID: 84865148627     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2179-1     Document Type: Article

References (39)

1. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York
2. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
3. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187 (Pubitemid 19032001)
4. Newman LA, Kuerer HM, Fornage B, Mirza N, Hunt KK, Ross MI et al (2001) Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg 181:313-318 (Pubitemid 32595677)
5. Brito RA, Valero V, Buzdar AU, Booser DJ, Ames F, Strom E et al (2001) Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 19:628-633 (Pubitemid 32119077)
6. Sugg SL, Ferguson DJ, Posner MC, Heimann R (2000) Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol 7:188-192 (Pubitemid 30215156)
7. Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R (1999) The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 35:1320-1325 (Pubitemid 29397430)
8. Stemmer SM, Rizel S, Hardan I, Adamo A, Neumann A, Goffman J et al (2003) The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study. J Clin Oncol 21:2713-2718 (Pubitemid 46606316)
9. Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR (2008) Internal mammary nodes in breast cancer: diagnosis and implications for patient management-a systematic review. J Clin Oncol 26:4981-4989
10. Veronesi U, Arnone P, Veronesi P, Galimberti V, Luini A, Rotmensz N et al (2008) The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol 19:1553-1560
11. Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M et al (2012) Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol 19:1508-1516
12. Mieog JSD, van der Hage JA, van de Velde CJH (2007) Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 94:1189-1200 (Pubitemid 47584766)
13. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685 (Pubitemid 28363030)
14. Deurloo EE, Tanis PJ, Gilhuijs KGA, Muller SH, Kröger R, Peterse JL et al (2003) Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39:1068-1073 (Pubitemid 36555863)
15. Altinyollar H, Dingil G, Berberoglu U (2005) Detection of infraclavicular lymph node metastases using ultrasonography in breast cancer. J Surg Oncol 92:299-303 (Pubitemid 41779287)
16. Aukema TS, Straver ME, Peeters MJTFDV, Russell NS, Gilhuijs KGA, Vogel WV et al (2010) Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer. Eur J Cancer 46:3205-3210
17. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401 (Pubitemid 24313232)
18. Estourgie SH, Tanis PJ, Nieweg OE, Valdés Olmos RA, Rutgers EJT, Kroon BBR (2003) Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 10:935-941 (Pubitemid 40486860)
19. Straver ME, Aukema TS, Olmos RAV, Rutgers EJT, Gilhuijs KGA, Schot ME et al (2010) Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients. Eur J Nucl Med Mol Imaging 37:1069-1076
20. Straver ME, Rutgers EJT, Russell NS, Oldenburg HSA, Rodenhuis S, Wesseling J et al (2009) Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer. Eur J Cancer 45:2284-2292
21. Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F et al (2008) Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 15:1316-1321
22. Pecha V, Kolarik D, Kozevnikova R, Hovorkova K, Hrabetova P, Halaska M, et al. (2011) Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Cancer. doi: 10.1002/cncr.26102
23. Peare R, Staff RT, Heys SD (2010) The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat 123:281-290
24. Koolen BB, Vrancken Peeters MJTFDV, Aukema TS, Vogel WV, Oldenburg HSA, van der Hage JA et al (2012) 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques. Breast Cancer Res Treat 131:117-126
25. Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G et al (2008) Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 26:4746-4751
26. Groheux D, Giacchetti S, Espié M, Vercellino L, Hamy A-S, Delord M et al (2011) The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study. J Nucl Med 52:1526-1534
27. Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N et al (2008) Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 8:165 (Pubitemid 351877805)
28. Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G et al (2007) A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 18:473-478 (Pubitemid 46359625)
29. Loo CE, Straver ME, Rodenhuis S, Muller SH, Wesseling J, Vrancken Peeters M-JTFD et al (2011) Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. J Clin Oncol 29:660-666
30. Vidal-Sicart S, Aukema TS, Vogel WV, Hoefnagel CA, Valdes Olmos RA (2010) Added value of prone position technique for PET-TAC in breast cancer patients. Rev Esp Med Nucl 29:230-235
31. Hodgson NC, Gulenchyn KY (2008) Is there a role for positron emission tomography in breast cancer staging? J Clin Oncol 26:712-720 (Pubitemid 351264383)
32. Rouzier R, Extra J-M, Klijanienko J, Falcou M-C, Asselain B, Vincent-Salomon A et al (2002) Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20:1304-1310 (Pubitemid 34177437)
33. Straver ME, Loo CE, Alderliesten T, Rutgers EJT, Vrancken Peeters MTFD (2010) Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg 97:1226-1231
34. Groheux D, Giacchetti S, Moretti J-L, Porcher R, Espié M, Lehmann-Che J et al (2011) Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol Imaging 38:426-435
35. Gil-Rendo A, Martínez-Regueira F, Zornoza G, García-Velloso MJ, Beorlegui C, Rodriguez-Spiteri N (2009) Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer. Br J Surg 96:166-170
36. Giordano SH, Kuo Y-F, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419-424 (Pubitemid 40528604)
37. Olivotto IA, Chua B, Allan SJ, Speers CH, Chia S, Ragaz J (2003) Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. J Clin Oncol 21:851-854 (Pubitemid 46606445)
38. Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK et al (2004) Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC). Am J Clin Oncol 27:407-410 (Pubitemid 39045254)
39. Çermik TF, Mavi A, Basu S, Alavi A (2008) Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging 35:475-483 (Pubitemid 351661670)